Suppr超能文献

新的预充式注射器带有一个焊接的 8 毫米超薄壁针头,可增强 2 毫升粘性溶液的手动注射用户体验。

User experience for manual injection of 2 mL viscous solutions is enhanced by a new prefillable syringe with a staked 8 mm ultra-thin wall needle.

机构信息

BD Medical - Pharmaceutical Systems, Becton Dickinson and Company , Le Pont De Claix, France.

Global Clinical Development, Becton Dickinson and Company , Le Pont De Claix, France.

出版信息

Expert Opin Drug Deliv. 2020 Oct;17(10):1485-1498. doi: 10.1080/17425247.2020.1796630. Epub 2020 Aug 9.

Abstract

OBJECTIVES

User experience was compared between a new pre-fillable 2.25 mL glass syringe equipped with an ultra-thin-wall (UTW) 8 mm staked needle and a marketed BD Neopak™ syringe equipped with a special-thin-wall (STW) 12.7 mm staked needle.

METHODS

Participants simulated subcutaneous injections with both syringes alone (formative Human Factors study) and in combination with a needlestick-prevention device (validation Human Factors study).

RESULTS

Usability results of both studies showed higher success rates for delivering the full dose of 2 mL viscous solution (30 cP) with the 8mmUTW syringe than with the 12.7mmSTW one (63% vs. 42% in the formative study). The use of the 8mmUTW syringe demonstrated also better ease of use and acceptance results and 72% of formative study participants preferred this new syringe over the current one when delivering the viscous solution. Using a shorter needle also showed a benefit in decreasing the injection-related anxiety. Besides, in the case of a non-recommended injection technique, the calculated risk of accidental intramuscular injection is reduced by 2 to 13 times with the 8mmUTW syringe.

CONCLUSION

Altogether, the results obtained demonstrated an improvement of the user experience with this new syringe compared to the current one in the manual delivery of 2 mL viscous solutions.

摘要

目的

比较一种新的预填充 2.25 毫升玻璃注射器,该注射器配备有超薄壁(UTW)8 毫米焊接针,和一种市售的 BD Neopak™注射器,该注射器配备有特殊薄壁(STW)12.7 毫米焊接针,两者的用户体验。

方法

参与者单独使用(形成性人因学研究)和与针防护装置联合使用两种注射器进行皮下注射模拟(验证性人因学研究)。

结果

两项研究的可用性结果均表明,在注射 2 毫升粘性溶液(30 cP)时,8mmUTW 注射器的全剂量递送成功率高于 12.7mmSTW 注射器(形成性研究中分别为 63%和 42%)。8mmUTW 注射器的使用还显示出更好的易用性和可接受性结果,在注射粘性溶液时,有 72%的形成性研究参与者更喜欢这种新注射器。使用较短的针也显示出在降低注射相关焦虑方面的益处。此外,在不推荐的注射技术情况下,8mmUTW 注射器将意外肌内注射的计算风险降低了 2 至 13 倍。

结论

总之,与当前的注射器相比,这种新注射器在手动输送 2 毫升粘性溶液时,用户体验得到了改善。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验